T1	PrimaryOutcome 49 77	time to clinical improvement
T2	TimeFrame 78 92	within 28 days
T3	OutcomeDefinition 105 232	patient discharged alive or reduction of 2 points on a 6-point disease severity scale (ranging from 1 [discharge] to 6 [death])
R1	MeasuredAt Arg1:T1 Arg2:T2	
R2	DefinedAs Arg1:T1 Arg2:T3	
T4	SecondaryOutcome 269 278	mortality
T5	SecondaryOutcome 280 297	time to discharge
T6	SecondaryOutcome 307 405	rate of viral polymerase chain reaction (PCR) results turned from positive at baseline to negative
T7	TimeFrame 406 423	at up to 72 hours
R3	MeasuredAt Arg1:T6 Arg2:T7	
T8	OutcomeDefinition 1110 1344	body temperature returned to normal for longer than 3 days, respiratory symptoms significantly improved without the need for oxygen support, and 2 consecutive negative PCR test results from nasopharyngeal swabs at least 24 hours apart
R4	DefinedAs Arg1:T5 Arg2:T8	
T9	SecondaryOutcome 1403 1412	mortality
T10	SecondaryOutcome 1474 1501	duration of hospitalization
T11	SecondaryOutcome 1633 1735	conversion of nasopharyngeal swab viral PCR results from positive at baseline to negative at follow-up
T12	TimeFrame 1745 1768	at 24, 48, and 72 hours
R5	MeasuredAt Arg1:T11 Arg2:T12	
T13	OutcomeDefinition 1414 1468	including analysis of time from randomization to death
R6	DefinedAs Arg1:T9 Arg2:T13	
T14	OutcomeDefinition 1503 1623	including analyses of time from randomization to discharge, time from admission to discharge, and 28-day discharge rates
R7	DefinedAs Arg1:T10 Arg2:T14	
T15	TimeFrame 262 268	28-day
R8	MeasuredAt Arg1:T4 Arg2:T15	
T16	OtherOutcome 1937 1957	rates of improvement
T17	TimeFrame 1958 1979	at days 7, 14, and 28
R9	MeasuredAt Arg1:T16 Arg2:T17	
T18	TimeFrame 1396 1402	28-day
R10	MeasuredAt Arg1:T9 Arg2:T18	
